Page last updated: 2024-11-06

lysergic acid diethylamide and Arthritis, Rheumatoid

lysergic acid diethylamide has been researched along with Arthritis, Rheumatoid in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DEL VALLADO, PF1
GIJON BANOS, J1
LARREA, A1

Other Studies

1 other study available for lysergic acid diethylamide and Arthritis, Rheumatoid

ArticleYear
[First clinical trials of U.M.L. 491 in rheumatoid arthritis].
    Revista clinica espanola, 1961, Feb-15, Volume: 80

    Topics: Arthritis; Arthritis, Rheumatoid; Lysergic Acid Diethylamide

1961